Professor Gordon Rustin

Professor Gordon Rustin

Rustin Oncology Ltd

General (internal) medicine, Medical oncology 01492156


  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Bupa Platinum consultant
Fee assured
Open Referral network


  • Video and telephone consultations

About me

Professor Gordon Rustin qualified from the Middlesex Hospital, London in 1971. He was appointed Senior Lecturer in Medical Oncology at the Charing Cross Hospital in 1984, but moved full-time to Mount Vernon Hospital to become Director of Medical Oncology in 1995. He retired from the NHS in 1918 but continues his private practice at BMI Bishops Wood Hospital as well as medico-legal work, refereeing papers and lecturing.

He was awarded an Honorary Professorship by UCL in 2001 and in 2011 created Professor of Cancer Therapy at the Institute of Cancer Research. He has published over 300 papers on management of gynaecological cancers and germ cell tumors, the use of tumor markers, especially CA 125, and on phase I, II and III trials. His definitions using CA 125 to define response and progression of ovarian carcinoma are internationally known as the “Rustin criteria”.

He gave the number 1 plenary lecture at the 2009 annual meeting of the American Society of Clinical oncology, presenting the results of the MRC OVO5 / EORTC 55955 trial which has since been published in the Lancet. This trial showed that patients benefit from delaying chemotherapy. Gordon Rustin through the use of use all his communication skills is slowly persuading the international community to accept these counterintuitive results and change practice.

As chief investigator of the phase I trials of DMXAA, CA4P and OXI4503 he has developed a unique experience of running trials of vascular disruptive agents (VDAs). He has led the world in introducing functional imaging into determining the activity of VDAs. For 5 years until 2008 he was chairman of the ovarian cancer sub group of the NCRI gynecological clinical studies group.

Areas of interest

Ovarian cancer;
Testicular cancer;
Gynaecological oncology
New Drug Development

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    Bishops Wood Hospital (5-50)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

    Bishops Wood Hospital (5-50)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.